Winton Group’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-23,865
| Closed | -$548K | – | 761 |
|
|
2023
Q1 | $548K | Buy |
23,865
+2,435
| +11% | +$55.9K | 0.03% | 654 |
|
|
2022
Q4 | $602K | Buy |
21,430
+19
| +0.1% | +$534 | 0.04% | 576 |
|
|
2022
Q3 | $606K | Sell |
21,411
-5,529
| -21% | -$156K | 0.04% | 584 |
|
|
2022
Q2 | $597K | Buy |
26,940
+4,802
| +22% | +$106K | 0.03% | 641 |
|
|
2022
Q1 | $644K | Buy |
22,138
+3,382
| +18% | +$98.4K | 0.03% | 608 |
|
|
2021
Q4 | $617K | Sell |
18,756
-11,756
| -39% | -$387K | 0.04% | 618 |
|
|
2021
Q3 | $1.41M | Buy |
30,512
+10,947
| +56% | +$505K | 0.08% | 335 |
|
|
2021
Q2 | $1.08M | Buy |
19,565
+4,765
| +32% | +$263K | 0.06% | 490 |
|
|
2021
Q1 | $764K | Sell |
14,800
-2,108
| -12% | -$109K | 0.04% | 623 |
|
|
2020
Q4 | $733K | Sell |
16,908
-36,441
| -68% | -$1.58M | 0.05% | 578 |
|
|
2020
Q3 | $1.87M | Buy |
53,349
+22,548
| +73% | +$789K | 0.06% | 561 |
|
|
2020
Q2 | $1.65M | Buy |
30,801
+24,923
| +424% | +$1.33M | 0.04% | 743 |
|
|
2020
Q1 | $209K | Buy |
+5,878
| New | +$209K | 0.01% | 1242 |
|
|
2019
Q4 | – | Sell |
-10,790
| Closed | -$350K | – | 1523 |
|
|
2019
Q3 | $350K | Buy |
+10,790
| New | +$350K | ﹤0.01% | 1219 |
|